SLDB vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

SLDB

35.0
AI Score
VS
ZBIO Wins

ZBIO

52.5
AI Score

Investment Advisor Scores

SLDB

35score
Recommendation
AVOID NEW MONEY

ZBIO

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SLDB ZBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -100.0% -100.0% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 35.0/100 52.5/100 ZBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD ZBIO

Relative Price Performance (Last 90 Days)

SLDB 1M: +30.6% · 3M: -16.3% ZBIO 1M: +14.1% · 3M: -1.7%

Current Technical Phase

SLDB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.3 · Price: $7.60

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.3 · Price: $28.70

Fundamentals Snapshot

Metric SLDB ZBIO
Market Cap — —
Forward P/E -4.7 -6.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% -1.0%
Gross Margin — -20.6%
Operating Margin 0.0% -7.6%
EPS -1.76 -10.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.